2023
The seventh CCRC takes place for the first time in Halifax, Nova Scotia and is CCRA’s first hybrid conference. There are 872 registrants and 673 abstract submissions.
The Patient Involvement in Cancer Research Program (PIP), held in conjunction with the CCRC, engages 36 patient partners, 13 attending in-person and 23 virtually.
The CCRA research investment data is refreshed to year 2021.
New Section on PartnershipAgainstCancer.ca
The Partnership is pleased to announce a brand new section - Topics - on its website PartnershipAgainstCancer.ca. Topics is now home to the most valuable information from Cancerview.ca, which ha... Read More »
The Partnership is pleased to announce a brand new section - Topics - on its website PartnershipAgainstCancer.ca. Topics is now home to the most valuable information from Cancerview.ca, which ha... Read More »
New Members Join the Alliance
The CCRA is pleased to announce the addition of two new member organizations: Bladder Cancer Canada and Myeloma Canada, and we welcome new representatives: Michelle Colero, Executive Director, Bladder Cancer Canada and Martine Elias, Executive Director, Myeloma Canada.
... Read More »
The CCRA is pleased to announce the addition of two new member organizations: Bladder Cancer Canada and Myeloma Canada, and we welcome new representatives: Michelle Colero, Executive Director, Bladder Cancer Canada and Martine Elias, Executive Director, Myeloma Canada.
... Read More »